Literature DB >> 11310924

High-grade adenoid cystic carcinoma originating from the lacrimal gland.

M Terasaki1, T Tokutomi, H Maruiwa, Y Sugita, H Harada, M Shigemori.   

Abstract

Among primary lacrimal gland tumors, adenoid cystic carcinoma (ACC) is the most common malignant epithelial neoplasm; it is characterized by local intracranial invasion. A case with unusual dumbbell-type intracranial extension representing cavernous sinus syndrome is described. A 49-year-old woman was admitted to our hospital with right cavernous sinus syndrome. Computerized tomographic (CT) scans and magnetic resonance (MR) imaging demonstrated well-enhanced intraorbital and middle fossa tumors mimicking multifocal mass lesions. Operative findings revealed an ACC originating from the lacrimal gland and extending into the right cavernous sinus and middle fossa along the nerve sheath in the superior orbital fissure. Although MR image findings of intracranial ACC often resemble the image findings for meningiomas, intracranial ACC is very aggressive in comparison with meningioma. It is best treated surgically and aggressively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11310924     DOI: 10.1007/bf02484288

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  9 in total

1.  Skull base invasion of adenoid cystic carcinoma of the lacrimal gland : a case report.

Authors:  Jae Il Lee; Young Zoon Kim; Eun Hee Lee; Kyu Hong Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-10-30

Review 2.  Lacrimal gland adenoid cystic carcinoma with high-grade transformation to myoepithelial carcinoma: report of a case and review of literature.

Authors:  Prokopios P Argyris; Stefan E Pambuccian; Zuzan Cayci; Charanjeet Singh; Konstantinos I Tosios; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2012-07-25

3.  A Rare Case of Orbital Adenoid Cystic Carcinoma Mimicking as Optic Nerve Glioma.

Authors:  Abhishek Gu; Sachin Daigavane
Journal:  Cureus       Date:  2022-06-12

4.  Salivary gland hybrid tumour revisited: could they represent high-grade transformation in a low-grade neoplasm?

Authors:  Henrik Hellquist; Alena Skalova; Bahram Azadeh
Journal:  Virchows Arch       Date:  2016-09-07       Impact factor: 4.064

5.  Adenoid Cystic Carcinoma with Transformation to High Grade Carcinomatous and Sarcomatoid Components: A Rare Case Report with Review of Literature.

Authors:  Anupurva Dutta; Pattatheyil Arun; Indu Arun
Journal:  Head Neck Pathol       Date:  2020-01-02

6.  Cytodiagnosis of intracranial metastatic adenoid cystic carcinoma: Spread from a primary tumor in the lacrimal gland.

Authors:  Kavita Mardi; Vijay Kaushal; Hari Uppal
Journal:  J Cytol       Date:  2011-10       Impact factor: 1.000

Review 7.  Cervical Lymph Node Metastasis in High-Grade Transformation of Head and Neck Adenoid Cystic Carcinoma: A Collective International Review.

Authors:  Henrik Hellquist; Alena Skálová; Leon Barnes; Antonio Cardesa; Lester D R Thompson; Asterios Triantafyllou; Michelle D Williams; Kenneth O Devaney; Douglas R Gnepp; Justin A Bishop; Bruce M Wenig; Carlos Suárez; Juan P Rodrigo; Andrés Coca-Pelaz; Primož Strojan; Jatin P Shah; Marc Hamoir; Patrick J Bradley; Carl E Silver; Pieter J Slootweg; Vincent Vander Poorten; Afshin Teymoortash; Jesus E Medina; K Thomas Robbins; Karen T Pitman; Luiz P Kowalski; Remco de Bree; William M Mendenhall; Jean Anderson Eloy; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2016-02-19       Impact factor: 3.845

8.  Adenoid cystic carcinoma of the parotid metastasising to the dura fifteen years post primary resection: A case report.

Authors:  Gulpembe Bozkurt; George Jayan; Abdullah Soydan Mahmutoglu
Journal:  North Clin Istanb       Date:  2020-04-07

9.  Aberrantly expressed GFRα-1/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk: a retrospective study of 51 LACC cases.

Authors:  Lin Liu; Liqiong Zhao; Jie Zhang; Guoxiang Song; Carol L Shields; Ruihua Wei
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.